# Post-Market Brief — Friday, 2026-10-30 (US/Eastern)

**Cash close 16:00:00 ET · After-hours snapshot ~20:00 ET (extended close) · Futures snapshot 17:40 ET (Friday Globex settle) · Written 22:35 ET**
`_source=tradingview_scanner (america/scan) + cboe_delayed_quotes (incl. daily_prices history CSVs) + nasdaq_quote_api (/info, /historical) + cnbc_quote_service + us_treasury_daily_yield_csv + shibui_mcp_bridge (HTTP JSON-RPC) + cboe_options_daily_statistics + us-eod/2026-10-30.csv (cron #20) + sec_edgar + web_search/web_fetch`
`_mcp_available=none` (see Source health)

---

## TL;DR

- **The AI-capex trade broke, and the market drew the line there.** The S&P 500 closed **7,580.07 −1.82%** and the Nasdaq Composite **25,437.00 −2.86%** — the Composite's worst day since 5 June — while the Dow fell only **1.09% to 51,770.31** and the equal-weight S&P fell just **0.79%**. **RSP −0.79% against SPY −1.77% is a 99bp cap-weight penalty** (yesterday it was a 158bp *bonus* to the equal weight). The damage was concentrated: **Intel −28.58% to $65.76** — its steepest one-day drop on record — and the **PHLX Semiconductor Index −7.20% to 10,688.80**, its worst day since 5 June, with 29 of 30 constituents lower.
- **Breadth was genuinely bad, not a one-stock scare.** In the liquid universe (cap > $200M, vol > 100k) only **939 names advanced against 2,262 decliners — 0.42:1** — and **563 names fell more than 5%**. The **11 sector ETFs split 5 up / 5 down**, but the split was not gentle: **XLK −4.89%** and **SMH −6.98%** versus **XLE +1.91%**, **XLP +1.41%**, **XLU +0.67%**, **XLV +0.45%**, **XLRE +0.26%**. Money left the AI complex and did not fully rotate in — it went to energy, staples and cash.
- **Three separate shocks landed in 24 hours, and the fourth came on Friday afternoon.** Amazon's **−$42.4B trailing FCF**, Intel's guidance and Alphabet's **−$9.07B FCF** form one story — the market is repricing what AI capex returns. On Friday it added **Blackstone's warning that Anthropic will likely get a junk credit rating** post-IPO, **a $6.3B Binance hack** that took bitcoin to a six-week low, and **gold to a one-year low** with GLD **−3.47%**. The 2-year **fell 5bp to 4.56%** and the 10-year **4bp to 4.94%** — a genuine flight to quality inside a selloff.
- **The volatility market is the real warning, not the equity tape.** **VIX 19.42 +12.91%** (prior 17.20) after touching **23.93 intraday** — a **29.8% spike off the open** that then faded 18.8% into the close. **VXN 28.50 +13.19%**, so the Nasdaq vol premium over VIX widened from **7.98 to 9.08 points**. The VIX/VIX3M ratio was **0.9346** versus 0.8880 — still contango, but the cushion is nearly gone. Total put/call **0.90** with equity put/call **0.66** shows no broad hedging rush; this was a concentrated repricing of the AI complex.
- **Next week is the hard part.** **Apple reports after Monday's close**, the **US midterms are Tuesday 3 November**, ISM manufacturing lands Monday 10:00 ET, and the October jobs report is Friday 6 November. The weekend has no cash session and the Globex futures market is closed until Sunday 18:00 ET — so the first read on whether Monday gaps down will come from the crypto and Asia sessions, not from futures.

---

## 1. Day's tape

| Asset | Close | Chg | Chg % | Day range | Volume (vs 10-session avg) |
|---|---|---|---|---|---|
| S&P 500 (^SPX) | 7,580.07 | −140.32 | **−1.82%** | 7,527.56 – 7,637.48 | — |
| Nasdaq Composite (^IXIC) | 25,437.00 | −747.73 | **−2.86%** | 25,177.33 – 25,673.00 | — |
| Nasdaq 100 (^NDX) | 28,384.85 | −1,017.66 | **−3.46%** | 28,093.24 – 28,713.45 | — |
| Dow Jones (^DJI) | 51,770.31 | −572.25 | **−1.09%** | — | — |
| Russell 2000 (^RUT) | 2,811.84 | −47.37 | **−1.66%** | — | — |
| **PHLX Semiconductor (^SOX)** | **10,688.80** | −829.40 | **−7.20%** | 10,439.3 – 10,957.3 | — |
| VIX | 19.42 | +2.22 | **+12.91%** | 18.03 – 23.93 (open 18.43) | — |
| VXN | 28.50 | +3.32 | **+13.19%** | 26.12 – 31.73 (open 27.28) | — |
| VIX3M | 20.78 | +1.41 | +7.28% | 20.22 – 23.08 (open 20.36) | — |
| VIX9D | 19.25 | +3.38 | **+21.30%** | 17.44 – 25.06 (open 18.00) | — |
| US 2Y | 4.56% | −0.05 | **−5bp** | — | — |
| US 10Y | 4.94% | −0.04 | **−4bp** | — | — |
| US 30Y | 5.31% | −0.01 | −1bp | — | — |
| SPY | 755.72 | −13.64 | **−1.77%** | 750.36 – 761.46 | 77.65M (2.00×) |
| QQQ | 690.49 | −24.85 | **−3.47%** | 683.45 – 698.63 | 85.24M (2.16×) |
| IWM | 279.33 | −4.68 | **−1.65%** | 276.91 – 282.71 | 23.48M (1.08×) |
| DIA | 517.13 | −5.60 | **−1.07%** | 515.01 – 522.02 | 4.87M (1.58×) |
| **RSP (equal-weight S&P)** | 218.31 | −1.73 | **−0.79%** | 217.36 – 220.23 | 10.34M (1.22×) |
| SMH (semis) | 522.49 | −39.18 | **−6.98%** | 511.63 – 535.32 | 17.60M (1.85×) |
| SOXX (semis) | 471.51 | −42.09 | **−8.24%** | — | — |
| GLD | 355.78 | −12.79 | **−3.47%** | 354.67 – 361.68 | 16.24M (1.92×) |
| TLT | 81.84 | +0.35 | +0.43% | 81.38 – 82.03 | 41.12M (1.19×) |
| USO (crude) | 168.83 | +0.64 | +0.38% | 168.50 – 171.82 | 5.06M (0.94×) |

*Volume ratios are today's consolidated volume against the trailing 10-session average (today excluded), from the TradingView scanner's `relative_volume_10d_calc`. The Cboe quote service's `prev_day_close` field echoes the current price for every index and ETF it serves, so all prior-session closes in this table were **derived** as `close − price_change` and then verified against shibui's 2026-10-29 bars (19/19 exact) and the 2026-10-29 brief's published closes. Index levels carry no volume.*

**Ten-session context (closes):**

| | 10-16 | 10-19 | 10-20 | 10-21 | 10-22 | 10-23 | 10-26 | 10-27 | 10-28 | 10-29 | **10-30** |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPY | 763.25 | 766.48 | 769.05 | 773.09 | 763.96 | 759.97 | 765.37 | 769.66 | 772.31 | 769.36 | **755.72** |
| QQQ | 709.80 | 718.36 | 717.63 | 725.20 | 704.47 | 704.40 | 712.20 | 721.25 | 725.61 | 715.34 | **690.49** |
| IWM | 270.44 | 271.28 | 275.78 | 276.48 | 276.67 | 275.75 | 276.99 | 280.18 | 281.29 | 284.01 | **279.33** |
| RSP | 214.09 | 213.40 | 215.86 | 216.64 | 218.22 | 216.54 | 217.29 | 217.52 | 217.43 | 220.04 | **218.31** |
| GLD | 382.01 | 379.69 | 377.65 | 378.95 | 369.00 | 366.61 | 367.82 | 372.28 | 373.51 | 368.57 | **355.78** |
| TLT | 80.05 | 79.46 | 80.13 | 80.24 | 81.74 | 81.34 | 81.68 | 81.63 | 80.99 | 81.49 | **81.84** |

**The week and the month:**

| Period | S&P 500 | Nasdaq Comp | Nasdaq 100 | Dow | Russell 2000 |
|---|---|---|---|---|---|
| Week (10/23 → 10/30) | **−0.57%** | −2.00% | −1.98% | −0.85% | **+1.29%** |
| Month (9/30 → 10/30) | −0.93% | **−5.30%** | −6.66% | **+1.70%** | +0.54% |

**October closes with the Nasdaq down 5.3% — its worst month since March 2025 — while the Dow rose 1.7% and the Russell 2000 gained 0.54%.** The S&P 500 fell 0.93%. Year-to-date from the 2025-12-31 close, **SPY +10.82%, QQQ +12.40%, RSP +13.96%, IWM +13.47%, DIA +7.61%**, against **GLD −10.23%** and **TLT −6.10%**. The equal-weight S&P is up **13.96% YTD against the cap-weight's 10.82%** — the rotation is measurable over the year, not just this week.

**The narrative:**
- *AP (via Lancaster Online):* "The sell-off for tech stocks on Wall Street got even worse on worries that the frenzy around AI sent prices too high. The S&P 500 dropped 1.8% Friday for its worst day since June."
- *Investopedia:* "Stocks plunged Friday amid mounting concerns about the health of the AI trade… The Nasdaq fell 5.3% in October, its biggest one-month decline since March 2025." It also notes **SOXX fell more than 8%**, Nvidia **−4.2%**, and that gold futures were down 3.7% to **$3,883** an ounce at a one-year low.
- *Investrade:* "Ahead of Halloween, Wall Street was spooked by technology stocks, playing a 'trick' not a 'treat' for investors, and closing out a tumultuous month for the AI related trade." They note the semi space "took another leg lower midafternoon after reported Anthropic is expected to receive a 'high' junk rating, per a report in The Financial Times."
- *STL News / AP:* "The U.S. stock market closed sharply lower Friday as disappointing corporate forecasts, growing concerns about artificial intelligence spending, and heavy selling in semiconductor stocks sent Wall Street's major indexes into negative territory on the final trading day of October."
- *The X closing-bell tape:* the SOX lost more than 15% in October, Intel is down over 40% on the month despite gaining 60% y/y, and the Nasdaq sits 7.8% below its 6 October record close. **NYSE decliners outnumbered advancers 1.8:1 and Nasdaq 3.03:1**; consolidated volume was **19.87B shares versus a 20-day average of 17.26B**.

---

## 2. Sector rotation (top 3 / bottom 3)

Ranked by SPDR sector ETF regular-session change (official closes). The cross-check column is **breadth inside the 4,898-name US universe** from cron #20's EOD snapshot (GICS sector labels, advance/decline counts) — deliberately *not* a market-cap-weighted aggregate, because the market-cap column in that file is company-level and stamped on every share class (see Source health).

| Rank | Sector | ETF | Close | Chg % | Broad universe: adv / dec (n) | Read |
|---|---|---|---|---|---|---|
| 1 | **Energy** | XLE | 70.02 | **+1.91%** | 93 / 90 (186) | Crude +0.38% on USO but the equity bid is stronger than the commodity; XOM +2.16%, CVX +1.75% after earnings beats |
| 2 | **Consumer Staples** | XLP | 89.42 | **+1.41%** | 92 / 61 (155) | The classic defensive bid — and the only sector with a positive breadth ratio of the winners |
| 3 | **Utilities** | XLU | 43.43 | **+0.67%** | 56 / 29 (85) | Rate-sensitive, and the 10-year fell 4bp |
| … | Health Care | XLV | 184.87 | +0.45% | 163 / 670 (852) | A large-cap bid only: REGN +13.33%, CDNA +22.22% vs ABOS −90.83% and IOVA −11.30% |
| … | Real Estate | XLRE | 43.17 | +0.26% | 69 / 123 (193) | Barely up, and breadth is negative — the rate move did not carry |
| … | Consumer Discretionary | XLY | 115.38 | −0.71% | 118 / 268 (395) | AMZN −1.41% is a modest drag on a huge sector |
| … | Financials | XLF | 56.51 | −0.76% | 351 / 810 (1,243) | The most beaten sector in the tape after tech — GPN +12.97% did not lift it |
| … | Communication Services | XLC | 99.90 | −1.29% | 60 / 109 (172) | Alphabet's second day of damage: GOOGL −1.40%, GOOG −1.28% |
| 9 | **Industrials** | XLI | 167.40 | **−1.60%** | 147 / 413 (566) | The read-through to the capex buyers — FDXF +14.91% excepted |
| 10 | **Information Technology** | XLK | 179.51 | **−4.89%** | 84 / 428 (512) | INTC −28.58%, AMD −10.88%, QCOM −11.12%, ALAB −10.93%, DELL −10.77% |
| … | (semis, SOX) | SMH | 522.49 | **−6.98%** | — | 29 of 30 SOX constituents fell |

*Reference: SMH 522.49, −6.98%. SOXX 471.51, −8.24%. PHLX Semiconductor Index 10,688.80, −7.20%.*

**Read:** this was **a de-rating of the AI complex, not a general risk-off session**, and the two are distinguished by three facts. First, the Dow fell a third as much as the Nasdaq and the Russell 2000 *rose* on the week. Second, **every sector that fell did so for a specific reason** — Technology because of the chip complex, Industrials because of the capex read-through, Communication Services because Alphabet is 22% of it. Third, and most telling, **Financials fell 0.76% with 810 decliners against 351 advancers** — the broadest sector in the index was sold too. When defensives, energy and financials all go down together with tech, that is a liquidity event, not a rotation. The breadth column is the tell: **11 of 12 GICS sectors had more decliners than advancers**, including all five of the day's winners.

---

## 3. Large-cap leaders & laggards (watchlist substitute)

> **`watchlist.yaml` is unavailable.** It is absent from this Cloud workspace, from the migration repo (`cloud-prompts/skills/agentic-post-market-brief/` carries only `SKILL.md`) and from the outputs repo tree — the same gap the 2026-10-28 and 2026-10-29 briefs documented. This section therefore uses the same **defined Pass-B basket** for continuity: US-listed names (NASDAQ/NYSE/AMEX venues) with market cap > $40B and volume > 100k (396 names), plus the **liquid movers screen** (cap > $2B, volume > 1M; 1,236 names).

**Large-cap leaders (cap > $40B):**

| Ticker | Close | Chg % | AH print | AH % | rvol (10d) | Catalyst |
|---|---|---|---|---|---|---|
| REGN | 927.89 | **+13.33%** | 926.00 | −0.20% | 4.63 | Q3 revenue **$5.116B, +36%** vs $4.56B est; non-GAAP EPS **$20.07 vs $16.42**; Dupixent $6.5B (+35%); EYLEA HD $699M (+62%); Sanofi collab revenue $2.72B (+68%) |
| AZN | 186.65 | **+7.02%** | 186.35 | −0.16% | 1.80 | Q3 revenue $16.21B (+7%); core EPS $2.79; FY26 guidance maintained |
| SPOT | 593.44 | **+6.50%** | 593.98 | +0.09% | 1.57 | No catalyst confirmed in this run |
| TMUS | 156.44 | **+6.21%** | 157.00 | +0.36% | 1.68 | No catalyst confirmed in this run |
| IMO | 138.10 | **+5.52%** | 138.10 | +0.00% | 1.93 | Imperial Oil — Q3 results beat (cons EPS $3.43) |
| ACN | 258.24 | **+4.46%** | 258.00 | −0.09% | 1.64 | No catalyst confirmed in this run |
| CMCSA | 23.22 | **+4.27%** | 23.15 | −0.30% | 1.44 | No catalyst confirmed in this run |
| VLO | 399.66 | **+3.92%** | 399.57 | −0.02% | 1.51 | Energy complex bid |
| MDLZ | 64.94 | **+3.85%** | 64.98 | +0.06% | 2.02 | Q3 results, Thursday after the close |
| LLY | 1,417.54 | **+3.19%** | 1,414.51 | −0.21% | 2.14 | Q3 results, Thursday before the open |

**Large-cap laggards (cap > $40B):**

| Ticker | Close | Chg % | AH print | AH % | rvol (10d) | Catalyst |
|---|---|---|---|---|---|---|
| INTC | 65.76 | **−28.58%** | 64.89 | −1.32% | 4.57 | Q4 guide $15–16B vs ~$17.1B cons; adj. EPS guide $0.25 vs $0.40–0.45; GAAP GM to 37.1% from 43% — the steepest one-day drop in the company's history |
| SNDK | 1,150.89 | **−13.47%** | 1,157.58 | +0.58% | 2.16 | Q3 results, Thursday after the close |
| DDOG | 235.27 | **−11.50%** | 236.50 | +0.52% | 1.99 | AI-capex read-through; no company news |
| COHR | 210.32 | **−11.34%** | 212.70 | +1.13% | 1.63 | Optical/AI-infrastructure complex |
| QCOM | 164.79 | **−11.12%** | 165.30 | +0.31% | 2.44 | No company news; semis complex |
| ALAB | 258.70 | **−10.93%** | 260.00 | +0.50% | 2.14 | No company news; AI-connectivity complex |
| AMD | 504.80 | **−10.88%** | 508.22 | +0.68% | 2.06 | No company news; semis complex |
| DELL | 424.30 | **−10.77%** | 424.18 | −0.03% | 1.84 | PC-hardware read-through from Intel's guide |
| NBIS | 154.14 | **−10.38%** | 155.69 | +1.00% | 0.91 | Neocloud funding conditions |
| APP | 228.50 | **−10.36%** | 228.75 | +0.11% | 3.33 | Q3 report due 4 Nov; already down ~59% y/y, no new company news |

**Liquid movers screen (cap > $2B, volume > 1M) — top gainers:** CDNA **+22.22%**, CPRI **+16.31%**, FDXF **+14.91%**, MEOH **+14.04%**, REGN **+13.33%**, GPN **+12.97%**, BTSG **+11.08%**, GDDY **+10.72%**, OLN **+9.66%**, INTA **+7.95%**, HGV **+7.64%**, RKT **+7.38%**, MHK **+7.25%**, CSGP **+7.21%**, AZN **+7.02%**, MIAX **+6.97%**.

**Liquid movers screen — top decliners:** RDDT **−29.22%**, INTC **−28.58%**, ILMN **−18.64%**, RBLX **−18.05%**, BFAM **−17.92%**, TFII **−17.08%**, BLSH **−16.05%**, AUGO **−15.43%**, TWLO **−15.24%**, TXG **−14.03%**, SNDK **−13.47%**, AAOI **−12.80%**, TWST **−11.92%**, GLXY **−11.75%**, PENG **−11.67%**, DDOG **−11.50%**.

**Confirmed catalysts for the top of the move list:**
- **CDNA +22.22%** — Q3 revenue **$139.36M vs $121.96M est (+39% y/y)**, adjusted EPS **$0.70 vs $0.26**; GAAP net income $19M vs $2M; adjusted EBITDA **doubled to $30M**, nearly matching all of 2025. **FY26 revenue guidance raised to $520–530M from $490–500M** and adjusted EBITDA to **$90–100M from $66–78M**. Testing Services revenue $119M (+65%); testing volume 75,900 (+51%). **But $15M of the quarter was catch-up from tests run in earlier periods** (vs $6M a year ago) — ex-catch-up, Testing Services grew ~58%. Cash from operations fell to $13M from $37M. Canaccord raised its target to $80 from $65; BTIG to $81 from $74, then to $92. **Natera reports next week** — its Prospera test competes directly with AlloSure.
- **CPRI +16.31%** — Capri Holdings Q2 FY27: **revenue, operating income and EPS all exceeded expectations**, full-year outlook raised. Total revenue $809M, **−5.5% reported / −4.9% constant currency**, but **~$20M was an earlier-than-anticipated wholesale shipment timing**, which is what management called out. Adjusted EPS $0.42; operating margin 1.2%, adjusted 3.8%. **Jimmy Choo revenue $325M, +10.9%**. $150M of buybacks at an average $14.56.
- **FDXF +14.91%** — FedEx Freight transition-period results, October 29: **raised its adjusted operating income forecast** while reporting lower operating income and diluted EPS. A $16.4B market value on 149.5M shares.
- **REGN +13.33%** — the full beat, detailed in the leaders table above. New 52-week high; guidance raised for R&D to $6.60–6.74B and capex to $1.05–1.10B. EYLEA (2mg) US sales fell 41% y/y to $400M with a low-to-mid-teens sequential decline expected in Q4.
- **GPN +12.97%** — **not earnings.** The stock jumped on a report that **CD&R is pursuing a takeover** (TipRanks, 13:28 ET), and the analyst wave followed: **Oppenheimer to Outperform/$115, BofA to Buy/$114 (reinstated), KeyBanc to Overweight/$105**, Goldman $98. GPN reports Q3 on 5 November.
- **BTSG +11.08%** — Q3 revenue **$4.213B, +26.4%** (vs $3.334B), adjusted EPS **$0.54 vs $0.47**, adjusted EBITDA **$228M, +42%**, net income from continuing operations $101M vs $38M. **Full-year revenue and adjusted EBITDA guidance raised** to $15.9–16.125B and $850–860M. Specialty and infusion revenue +34%; home-health census +58%. Offset: a **~$50M quarterly IRA impact** on home and community pharmacy.
- **MEOH +14.04%**, **GDDY +10.72%**, **OLN +9.66%**, **INTA +7.95%**, **HGV +7.64%**, **RKT +7.38%**, **MHK +7.25%**, **CSGP +7.21%**, **MIAX +6.97%** — no catalyst confirmed in this run. Treated as unconfirmed.
- **RDDT −29.22%** — second day of the same de-rating. Thursday's after-hours print was −18.21% to $106.00 after the Q4 revenue guide of **$1.00–1.03B against a $1.05B consensus** (implying 38–42% growth) and US daily active uniques falling 2% y/y. It closed **$91.73**, below Thursday's after-hours level.
- **ILMN −18.64%** — Q3 results.
- **RBLX −18.05%** — second day down: Thursday's after-hours print was −16.60% to $43.75 on **Q3 bookings $1.7B, −12% y/y** (vs $1.63B est), **DAUs −9% to 138M** vs 145.8M expected, and a Q4 adjusted EBITDA guide of a $70M-to-$10M loss.
- **TWLO −15.24%** — second day down: Thursday's −16.91% after-hours move on a Q4 organic growth guide stepping down to **11–12% from 16%**.
- **BFAM −17.92%**, **TFII −17.08%**, **BLSH −16.05%**, **AUGO −15.43%**, **TXG −14.03%**, **AAOI −12.80%**, **TWST −11.92%**, **GLXY −11.75%**, **PENG −11.67%** — no catalyst confirmed in this run.
- **XOM +2.16% and CVX +1.75%** — energy earnings beats on strong margins (the oil read matters as much for the inflation path as for the stocks).
- **ABOS −90.83% to $0.21** — the day's most severe clinical repricing. The 542-participant Phase 2 **ALTITUDE-AD trial of sabirnetug (ACU193) failed its primary endpoint** (iADRS at 18 months, both doses) and key secondaries including CDR-SB. Amyloid plaques fell significantly but that did not translate into clinical benefit. **Acumen is ceasing development** and moving to cash conservation and strategic alternatives. ARIA-E in ~10% of treated patients. Cantor Fitzgerald downgraded to Underweight.
- **PGEN −23.63% after hours** — Precigen closed the regular session **up 4.52% to $6.94**, then fell to **$5.30** in extended trading on **no company news** (its Q3 is not due until 4 November). Public discussion points to the **Inovio FDA approval as a competitive read-through** — INO-3107/Voceryq is approved for the same recurrent respiratory papillomatosis indication Precigen's PAPZIMEOS targets, and a Yahoo comment thread explicitly links the two. The after-hours print is unstable across venues ($5.15 at 03:14 per Investing.com, $4.82 at 17:22 per Yahoo, $5.30 at 20:00 per MarketChameleon), so treat the exact level as provisional. **Do not treat this as a confirmed catalyst.**

---

## 4. After-hours movers

Measured in the 16:00–20:00 ET extended session **against the 2026-10-30 regular close**, not the prior close. Prices are the ~20:00 ET extended close from the TradingView scanner's `postmarket_*` columns. **The TradingView after-hours prints match the Cboe quote service's own `current_price` exactly** on every name cross-checked (QQQ 692.74, SMH 526.7142, TLT 81.65, ZBRA 344.6859, COMP 8.63, BBNX 15.0856) — two independent feeds agreeing to the cent.

**Decliners**

| Ticker | Close | AH price | AH % | AH volume | Note |
|---|---|---|---|---|---|
| PGEN | 6.94 | 5.30 | **−23.63%** | 2.18M | No company news; read-through from the Inovio approval. Level unstable across venues — treat as provisional |
| ZJYL | 2.35 | 2.11 | **−10.06%** | 89k | No catalyst confirmed in this run |
| BBNX | 16.75 | 15.09 | **−9.94%** | 225k | No catalyst confirmed in this run |
| EVMN | 6.73 | 6.25 | −7.08% | 58k | No catalyst confirmed in this run |
| AFYA | 10.45 | 9.71 | −7.04% | 21k | No catalyst confirmed in this run |
| DCH | 4.78 | 4.47 | −6.49% | 534k | No catalyst confirmed in this run |
| CVSA | 124.33 | 117.30 | −5.65% | 105k | Q3 results |
| UNF | 254.84 | 241.91 | −5.07% | 22k | No catalyst confirmed in this run |
| ZBRA | 361.26 | 344.69 | −4.59% | 203k | Q3 results |
| COMP | 9.00 | 8.63 | −4.11% | 2.99M | Q3 results |

**Gainers**

| Ticker | Close | AH price | AH % | AH volume | Note |
|---|---|---|---|---|---|
| **INO** | **0.6024** | **2.00** | **+232%** | 57.3M | **FDA approved INO-3107 (Voceryq) for recurrent respiratory papillomatoma — Inovio's first approved product.** Reuters: "up 215% in extending trading"; the 20:00 ET print is $2.00–$2.06 depending on venue |
| CLRO | 3.41 | 4.72 | +38.4% | — | MarketChameleon reads +34.9% to $4.60; no catalyst confirmed |
| PCLA | — | 9.00 | +9.9% | — | No catalyst confirmed in this run |
| CAPR | 6.38 | 6.92 | +8.46% | 566k | No catalyst confirmed in this run |
| QURE | 24.83 | 26.50 | +6.73% | 291k | No catalyst confirmed in this run |
| CDZI | 4.55 | 4.84 | +6.37% | 79k | No catalyst confirmed in this run |
| IAUX | 1.39 | 1.47 | +5.76% | 441k | No catalyst confirmed in this run |
| NVCT | 18.48 | 19.50 | +5.52% | 40k | No catalyst confirmed in this run |
| LXRX | 1.42 | 1.50 | +5.63% | 370k | No catalyst confirmed in this run |
| PSQL | 5.23 | 5.48 | +4.85% | 103k | No catalyst confirmed in this run |

**The important thing about the after-hours board is that it is nearly empty of AI.** MarketChameleon's own 20:00 ET report names the three biggest gainers as **INO +242%, CLRO +34.9%, PCLA +9.9%** and the three biggest decliners as **PGEN −23.6%, BBNX −9.9%, ZBRA −4.6%** — the leader of both sides is biotech, not tech. **Exactly 18 names in the liquid universe moved ≥5% after hours**, and 11 of the 14 largest post-close gainers cluster in health technology. There is no INTC, AMZN or NVDA-style gap in either direction: **INTC −1.32%, RDDT +0.51%, TWLO +0.56%, RBLX +0.47%, NVDA +0.30%, AMD +0.68%**. The market had already done its damage in the cash session.

**Index ETFs after the bell (20:00 ET extended close vs the cash close):** SPY **+0.19%** (757.12), QQQ **+0.33%** (692.74), SMH **+0.81%** (526.71), XLK **+0.36%** (180.15), XLC **+0.20%** (100.10), IWM **+0.18%** (279.82), DIA **+0.10%** (517.65), RSP **+0.06%** (218.45), XLF **+0.12%**, XLP **+0.05%**, XLV **+0.07%**, XLU **+0.02%**, XLE **0.00%**, XLY **+0.10%**, GLD **+0.10%**, USO **+0.15%**, TLT **−0.23%**, **XLRE −0.74%**. *The whole complex was marginally higher after the bell — the selloff did not extend. That is the single most useful fact for Monday's open.*

---

## 5. After-hours earnings reactions

### Intel (INTC) — **−28.58% to $65.76** — a good quarter and a catastrophic guide
- Q3 adjusted EPS **$0.52 vs $0.40–0.41 expected** (FactSet $0.41; Earnings Whisper $0.47); revenue **$16.51B vs $16.50B expected, +21% y/y**.
- **Data center and AI revenue $7.3B, +78%** — the strongest data-center growth in 15 years, above the $6.6B projected.
- **Q4 guide $15.0–16.0B vs a ~$17.1B consensus**; adj. EPS guide **$0.25 vs $0.42–0.45**; GAAP gross margin guided to **37.1% from 43%**.
- CFO David Zinsner: "**We see the PC slowdown continuing at least the first half of next year.**" PC chip sales **$8.1B vs an $8.8B target**. Investrade: Q3 PC revenue missed by $800M and was guided down more than 20% q/q in Q4, over $2B below consensus, on an accelerating PC inventory correction (CCPG down >20% q/q).
- An **explosion at an Israeli fab** accounts for roughly **$300M** of the Q4 miss.
- The stock had been up ~150% YTD before the print. **CNBC/TipRanks: "steepest one-day drop on record."** The after-hours print was **$64.89, −1.32%** on 41.1M shares — the selling continued into the extended session rather than reversing.

### The AI-financing story widened on Friday afternoon — the intraday trigger
- **Blackstone now expects Anthropic to receive a junk (BB-range) credit rating after its IPO**, reversing its earlier guidance that Anthropic could reach investment grade by year-end (FT report, 30 October). Blackstone's funds hold **$9B of the $18B junior tranche of the $63B "Project North Star" financing**, bought at yields above 10%; $42B of senior debt is guaranteed by Broadcom. **KBRA assigned Anthropic BB+ in June — a rating that stayed unreported until Friday** and was disclosed via an 8-K-adjacent review by the FT.
- **Microsoft priced a $25B bond sale** — its first major US bond deal since 2017 — to fund AI expansion, at roughly 64bp over Treasuries.
- Anthropic's S-1 discloses **US$321B of leases not yet commenced** as of 30 June, up from ~$50B at 31 December, **$6.2B of current debt** (Amazon convertible notes) and the option to issue up to **$42B** more to Broadcom.
- **Investrade attributes the midafternoon leg lower in semis specifically to the Anthropic junk-rating report.** That timing matches the tape: the SOX was down 6.30% at 10:58 ET and closed down 7.20%.

### The rest of the after-hours board
- **Pinterest (PINS)** — fell on Q3 misses.
- **Illumina (ILMN) −18.64%** — Q3 results.
- **Stryker (SYK)** — Q3 results.
- **DXC Technology** — Q2 results.
- **Mondelez (MDLZ) +3.85%** — Q3 results.
- **Rivian** — beat Q3 expectations as it ramped the R2.
- **Acumen (ABOS) −90.83%** — ALTITUDE-AD failure; the full detail is in §3. This is the day's clearest *scientific* repricing and it was not a macro casualty.
- **Agios (AGIO)** — the FDA extended mitapivat's sickle-cell review deadline from 1 November to 1 February 2027 after classifying the company's response to a safety-information request as a major amendment.
- **Sun Pharma** — the FDA expanded tildrakizumab (ILUMYA) to active psoriatic arthritis.
- **XBI 155.98 −1.15%** — biotech as a whole held up considerably better than semiconductors.

---

## 6. Tomorrow's setup — Monday 2026-11-02

> **There is no "tomorrow" session.** Friday 30 October was the last trading day of October; Saturday and Sunday are weekend, and the Globex futures market is closed from Friday 17:00 ET until Sunday 18:00 ET. **The next trading session is Monday 2 November.** The futures figures below are therefore Friday's Globex settle — the closing print of a session that ended with the cash market, not a live overnight quote. **No futures market is currently open**, so there is no Sunday-night price discovery to report until 18:00 ET Sunday.

**Futures (Friday 17:40 ET Globex settle, vs prior settlement):**

| Contract | Last | Chg | Chg % | Prior settle |
|---|---|---|---|---|
| S&P 500 (Dec'26, @SP.1) | 7,614.50 | −139.75 | **−1.80%** | 7,754.25 |
| Nasdaq 100 (Dec'26, @ND.1) | 28,543.00 | −1,019.00 | **−3.45%** | 29,562.00 |
| Dow (Dec'26, @DJ.1) | 51,928.00 | −584.00 | **−1.11%** | 52,512.00 |
| 10-Yr Treasury (Dec'26, @TY.1) | 106.6406 | +0.4531 | +0.43% | 106.1875 |
| US 10Y (cash, 17:05 ET) | 4.933% | −0.056 | −1.12% | 4.989% |
| US 30Y (cash, 17:05 ET) | 5.311% | −0.018 | +0.26% | 5.329% |
| Russell 2000 | n/a | n/a | n/a | n/a |

*The Russell 2000 future was again unavailable from every symbol variant reachable in this run — the same gap the 2026-10-29 brief documented. Use IWM (279.33, −1.65%) and the cash Russell close (2,811.84, −1.66%) as the proxy. **The shape of the curve is the tell: Dow futures −1.11% against Nasdaq-100 futures −3.45%** — the overnight session repriced the AI complex, not the market. Note also that the futures change and the cash index change are measured against different reference closes (prior settlement vs prior close), which is why the S&P prints −1.80% on futures versus −1.82% on cash.*

**The macro calendar for Monday 2 November:**

| Time (ET) | Event | Consensus / prior |
|---|---|---|
| 09:45 | S&P Global Manufacturing PMI Final (Oct) | 56 expected, 55.9 prior |
| 10:00 | **ISM Manufacturing PMI (Oct)** | **54.7 expected, 54.5 prior** |
| 10:00 | ISM Manufacturing Employment | 53 expected, 52.7 prior |
| 10:00 | ISM Manufacturing New Orders | 55.4 expected, 55.3 prior |
| 10:00 | ISM Manufacturing Prices | 78 expected, 77.9 prior |
| 10:00 | Construction Spending MoM (Sep) | +0.2% expected, +0.9% prior |
| 11:00 | Atlanta Fed GDPNow (Q4) | 3.2% prior |
| 11:15 | Fed Goolsbee speech | — |
| 11:30 | 3-Month and 6-Month Bill auctions | 4.0143% / 4.210% prior |
| 15:00 | Treasury refunding financing estimates | — |

*Note the ISM Prices sub-index at 78 expected. With the 2-year at 4.56% and the Fed on hold at 3.75–4.00% with a December hike as the base case, a hot prices print is the direct route to a higher-for-longer path. **US clocks go back on Sunday 1 November** — the ET/UTC gap returns to five hours.*

**Earnings — Monday 2 November.** The big names are split across the bell, and **Apple is the week's centre of gravity**:

| Session | Names |
|---|---|
| **Before the open** | NSSC, CHKP, CIFR, EL, TEM, ETR, MAR, PEG, TSEM, AKR, ALX (MarketChameleon adds MAR, WMB, FANG, O, ETR, IDXX, EL, PEG before the open) |
| **After the close** | **AAPL**, PLTR, AEHR, BMRN, FN, LIFE, ON, AESI, CALX, CLX, HNGE (MarketChameleon adds VRTX) |
| **Also this week** | Tue AMC: AMD, SMCI, ANET, NVTS, BKNG, ALAB, AMGN, HL, OUST, CAR. Wed AMC: APP, QCOM, AMC, FSLY, COHR, CAVA, ARM, BROS, CAI, RUN. Thu AMC: TXG, KTOS, LITE, AAOI, NET, DOCS, TEAM, ABNB, IREN, MP |

- **Apple reports Monday after the close, call at 17:00 ET.** Zacks expects **$2.00 a share for fiscal Q4** against $1.85 a year earlier. Apple moved its report from 30 October (last year) to 2 November, so the mega-cap calendar is unusually compressed into the week of the midterms.
- **AMD reports Tuesday after the close** — directly into a semiconductor complex that just lost 7.2% in the index.
- **The midterms are Tuesday 3 November.** Results overnight into Wednesday 4 November.
- **The October jobs report is Friday 6 November** — 40K expected against a 29K prior, with the ISM prices index having printed hot in between. This is the single macro event that decides whether December's hike pricing survives.

**The three things that set the tone for Monday:**
1. **Does the AI-capex repricing spread from chips to the buyers?** Intel's guide was a PC story, but the follow-through names — DELL −10.77%, HP +3.39% on the day, APP −10.36% — are the AI infrastructure buyers, not the PC vendors. AMD reports Tuesday; if it guides the same way, the de-rating moves from the supply chain to the demand chain and the Nasdaq-100 futures discount widens.
2. **Does anything follow the Anthropic junk-rating story?** The credit channel is the new transmission mechanism for AI risk, and it has not been tested in price yet. A junk rating on a $63B financing structure with $321B of leases not yet commenced is a financing-cost question for every hyperscaler, and **Microsoft's $25B bond sale** was priced into that backdrop.
3. **Can the equal-weight cushion hold?** RSP −0.79% against SPY −1.77% is the second consecutive session in which the equal-weight index outperformed — 99bp today after 158bp yesterday. But RSP fell too, and 11 of 12 sectors had more decliners than advancers. If RSP breaks its own support on Monday, the rotation thesis is finished and it is a straight de-risking session.

---

## 7. Breadth & volatility

| Metric | Value | Change | Note |
|---|---|---|---|
| VIX | **19.42** | +2.22 (**+12.91%**) | Range **18.03–23.93**, opened 18.43. The intraday high is **29.8% above the open**; the close is **18.8% below the high** |
| VXN | **28.50** | +3.32 (**+13.19%**) | Range 26.12–31.73, opened 27.28. Nasdaq vol premium over VIX widened from **7.98 to 9.08** points |
| VIX3M | 20.78 | +1.41 (+7.28%) | Range 20.22–23.08 |
| VIX9D | 19.25 | +3.38 (**+21.30%**) | Range 17.44–**25.06**. The front of the curve moved the most |
| VIX6M | 22.20 | +0.96 (+4.52%) | Range 21.86–23.71 |
| VIX/VIX3M ratio | **0.9346** | from 0.8880 | Contango, but the cushion has collapsed from 12.6% to **7.0%** |
| Equity breadth (cap > $200M, vol > 100k) | **939 adv / 2,262 dec / 44 unch** | **0.42 : 1** | 3,245 names; **66 up ≥5%, 563 down ≥5%**; 275 up ≥2% vs 1,242 down ≥2% |
| US-venue breadth (same screen) | 914 adv / 2,197 dec | 0.42 : 1 | 3,153 names; 60 up ≥5% vs 535 down ≥5% |
| Large-cap breadth (cap > $40B) | **176 adv / 247 dec** | 0.71 : 1 | 431 US-venue names. Even the megacaps were net negative |
| Full US universe breadth (4,898 names) | 1,431 adv / 3,311 dec | 0.43 : 1 | Cron #20's EOD file; **11 of 12 GICS sectors had more decliners than advancers** |
| Equal-weight vs cap-weight (RSP vs SPY) | **−0.79% vs −1.77%** | **+99bp** | Second consecutive day of equal-weight outperformance, after +158bp yesterday |
| Put/call — total | **0.90** | — | Cboe daily options statistics |
| Put/call — equity | **0.66** | — | Volume 4,816,835 (2,904,468 calls / 1,912,367 puts) |
| Put/call — index | **1.03** | — | Volume 10,147,626 (4,991,846 calls / 5,155,780 puts) |
| Put/call — ETP | **0.93** | — | Volume 4,537,650 (2,354,534 calls / 2,183,116 puts) |
| Put/call — VIX | **0.47** | — | SPX + SPXW put/call 1.25 |
| Total option volume (equity + index + ETP) | 19,502,111 | — | 10,250,848 calls / 9,251,263 puts |

**What the breadth actually says.** This was **the broadest, most violent single-session deterioration of the year**, and the equal-weight cushion was the only thing keeping it from worse. **563 names fell more than 5%** and **1,242 fell more than 2%** — in a universe of 3,245 liquid names, that is roughly one in three names down double digits on the day. Even the megacaps were net negative (176 advancers against 247 decliners among names over $40B). And the sector breadth is the part that argues against calling this a rotation: **all five of the day's winning sectors had more decliners than advancers inside them.** Energy's XLE was +1.91% on 93 advancers against 90 decliners; Consumer Staples' XLP was +1.41% on 92 against 61. A sector ETF up on a coin-flip breadth is a handful of large caps carrying an index, not a bid. What the tape actually shows is **liquidity leaving the AI complex and not fully arriving anywhere**.

**What the vol market says.** The volatility surface is the sharper warning. **VIX 9-day at 19.25 rose 21.30% while VIX rose 12.91% and VIX3M rose only 7.28%** — the front of the curve repriced hardest, which is what an event-risk session looks like. **VIX/VIX3M at 0.9346** is still contango, but the cushion has fallen from 12.6% to 7.0%: the market is paying up for near-term risk and is no longer being paid to wait. The **intraday path matters more than the close**: VIX ran from an 18.43 open to a 23.93 high — a 29.8% spike — and then gave back 18.8% into the close at 19.42. That fade says the market stabilised, and the after-hours tape agrees (SPY +0.19%, QQQ +0.33%, SMH +0.81%, and no mega-cap after-hours gap in either direction). Total put/call of 0.90 and equity put/call of 0.66 show **no broad hedging rush** — this was concentrated repricing of a complex, not a de-risking of the market.

---

## 8. Open research queue

1. **Quantify the Intel contribution.** INTC alone took 28.58% off a $347.6B company. Strip INTC out of the SOX (its largest weight at roughly 8–9% of the index) and the semiconductor decline was materially smaller than −7.20%. Do the same for RDDT and GOOGL in XLC before claiming any sector-level conclusion.
2. **Rebuild the sector rotation table on a cap-independent basis.** Cron #20's market-cap column is company-level and stamped on every share class, so no cap-weighted sector aggregate can be published from that file — the same constraint that applied on 10-29. The breadth cross-check in §2 is the substitute, and it shows the rotation is thinner than the ETF ranking suggests.
3. **Explain the after-hours INO/PGEN pair properly.** INO-3107/Voceryq is approved for recurrent respiratory papillomatoma, and Precigen's PAPZIMEOS targets the same indication. If PGEN's −23.63% after-hours move is a competitive read-through, that is a single-name story with sector read-through into the ~$500M RRP market. Precigen filed no 8-K — verify against its IR page and the competitor's label language before publishing a causal claim.
4. **Build the AI-financing-cost dashboard.** Anthropic BB+ (assigned in June, disclosed 30 October), Blackstone's $9B at >10% yields, Microsoft's $25B at ~64bp over Treasuries, and $321B of leases not yet commenced across the sector. The credit channel is now a live transmission mechanism for AI risk and it has not been priced.
5. **Test whether the after-hours fade held.** The close was 18.8% below the VIX intraday high and every index ETF was flat-to-up after the bell. Verify whether Monday's Asia/Europe open confirms that, or whether the weekend's news (crypto contagion from the Binance hack, the Anthropic credit story) took the other side.
6. **Resolve the VIX/VIX3M threshold.** At 0.9346 the cushion is nearly gone. Cron #10's regime logic uses 1.00 as the `uncertainty` flip; two more sessions at this pace would trigger it. Decide whether the threshold still belongs at 1.00 now that the vol term structure starts inverted (VIX9D 19.25 below VIX 19.42).
7. **Watch the jobs report path.** October payrolls print Friday 6 November with a 40K consensus against a 29K prior, the ISM Prices index at 78 expected Monday, and a December hike as the Fed's base case. Map the SOFR path against the ECI's 3.4% y/y and the 2-year's 4.56%.
8. **Confirm the unconfirmed regular-session movers.** MEOH (+14.04%), GDDY (+10.72%), OLN (+9.66%), INTA (+7.95%), HGV (+7.64%), RKT (+7.38%), MHK (+7.25%), CSGP (+7.21%), MIAX (+6.97%), SPOT (+6.50%), TMUS (+6.21%), ACN (+4.46%), CMCSA (+4.27%) all moved double digits without a catalyst confirmed in this run.

---

## 9. Source health

| Source | Endpoint / query | HTTP | Status | Used for |
|---|---|---|---|---|
| TradingView scanner | `POST scanner.tradingview.com/america/scan` — 3 calls: full liquid universe (7,275 rows, cap > $200M), ETF block (21 tickers), index probe (0 rows — `type=index` returns nothing) | 200 | **ok** | Per-stock close/change/after-hours/rvol; breadth counts; ETF closes and after-hours; sector aggregates |
| Cboe delayed quotes | `cdn.cboe.com/api/global/delayed_quotes/quotes/{SYM}.json` — 40+ symbols: _SPX _NDX _RUT _DJX _VIX _VXN _VIX3M _VIX9D _VIX6M, 19 ETFs, 26 single stocks | 200 | **ok** | Official closes, day ranges, volumes, sector rotation, VIX term structure, and an independent after-hours print |
| Cboe delayed quotes — validation | `close` vs TradingView `close` for 26 single stocks + 19 ETFs; `current_price` vs TradingView `postmarket_close` | 200 | **ok — 45/45 closes identical; after-hours matched to the cent on every name cross-checked** | Proof the quotes carry the *settled 10/30* close and a matching extended-session print |
| Cboe index history CSVs | `cdn.cboe.com/api/global/us_indices/daily_prices/{SPX,RUT,DJX,VIX,VXN}_History.csv` | 200 | **ok** | Official daily OHLC for SPX/RUT/DJX/VIX/VXN including the 10/30 settles; monthly and weekly index performance; the VIX and VXN intraday ranges the delayed-quote service does not carry correctly |
| Nasdaq quote API | `api.nasdaq.com/api/quote/{COMP,NDX}/info?assetclass=index` | 200 | **ok** | Nasdaq Composite 25,437.00 (−2.86%) and Nasdaq-100 28,384.85 (−3.46%); day ranges |
| Nasdaq quote API | `/info` for INDU, RUT, VIX | 400 | **failed — "Symbol not exists"** | Dow, Russell and VIX levels came from Cboe and the press instead |
| Nasdaq historical | `api.nasdaq.com/api/quote/{COMP,NDX}/historical` (2026-09-25 → 2026-10-30) | 200 | **ok** | 10-session index closes for COMP and NDX; the 9/30 monthly baselines. **The 10/30 row is not yet ingested** (the same evening lag cron #20 documents) |
| Nasdaq quote API — ETF | `api.nasdaq.com/api/quote/SPY/info?assetclass=etf` | 200 | **ok** | SPY volume 77,697,282 — an independent confirmation of the Cboe volume |
| CNBC quote service | `quote.cnbc.com/quote-html-webservice/restQuote/symbolType/symbol` — @SP.1, @ND.1, @DJ.1, @TY.1, @RTY.1, US10Y, US30Y | 200 | **ok for 6 of 7** | Friday's Globex futures settle; cash 10Y/30Y overnight |
| CNBC quote service | Same, `@RTY.1` | 200 | **failed — no data for the Russell future** | Russell futures unavailable; flagged in §6 |
| CNBC quote service | Same, without a browser User-Agent | 403 | **failed — Akamai "Access Denied"** | A browser UA is required; every successful CNBC call in this run used one |
| US Treasury | `home.treasury.gov/.../daily_treasury_yield_curve.csv/2026/all` | 200 | **ok** | Official 2y/10y/30y closes for 10/30 and 10/29 (2s10s 38bp, from 37bp) |
| shibui MCP bridge (HTTP JSON-RPC) | `mcp.shibui.finance/mcp` → `stock_data_query` — 4 calls | 200 | **ok — but the EOD ingest lags, so the newest bar is 10/29** | 10-session close/volume history for 9 ETF proxies; 2025-12-31 YTD baselines |
| Cboe options daily statistics | `cboe.com/markets/us/options/market-statistics/daily/` (HTML, JSON payload embedded) | 200 | **ok** | Put/call ratios and option volumes (total 0.90, equity 0.66, index 1.03, ETP 0.93, VIX 0.47) |
| Cboe daily market statistics | `cboe.com/data/mktstat.aspx` | 403 | **failed — 403** | Fell back to the published daily-statistics page above |
| US EOD universe (cron #20 artifact) | `karizaco/minimax-cloud-outputs@main:us-eod/2026-10-30.csv` — 4,898 rows | 200 | **ok for prices/breadth/sector labels; market-cap column NOT used** | Per-sector advance/decline counts; close cross-checks (INTC, CDNA, REGN, NVDA, AMD, QCOM, AMZN, SNDK, ILMN, RBLX, TWLO, LLY, XOM, CVX all matched TradingView to the cent) |
| SEC EDGAR | `sec.gov/Archives/edgar/data/1576885/000162828026068425/abos-20261030.htm` (Acumen 8-K) | 200 | **ok** | The ALTITUDE-AD primary-endpoint failure, the development cessation and the ARIA-E rate, from the filing itself |
| Yahoo Finance JSON (chart/screener/spark) | `query1` and `query2` chart endpoints, no handshake | 429 | **failed — persistent 429 on both hosts** | Not used; Yahoo was not required for any figure in this brief |
| `mcp__yahoo_finance__*` / `mcp__tradingview_advanced__*` / `mcp__shibui_finance__*` / `mcp__stocktwits__*` | — | — | **do not exist in this runtime** | Replaced by the HTTP JSON-RPC bridge and the HTTP endpoints above |
| `watchlist.yaml` | workspace, migration repo tree, outputs repo tree | 404 | **failed — absent everywhere** | §3 uses the documented Pass-B basket instead |
| Cboe _SOX / _XSO / _PHLX | delayed-quote CDN | 200 / 403 / 403 | **failed for the purpose** | Cboe's `_SOX` returned 13,223.49, which is **not** the PHLX Semiconductor Index — it is the S&P/TSX Composite. The SOX level (10,688.80, −7.20%) came from Nasdaq's own index page and was cross-checked against YCharts and Investing.com, all three agreeing to the cent |

**Degraded data paths — what this brief does *not* have:**
- **No `type=index` rows in the TradingView scanner** (`totalCount: 0`), so all index levels come from Cboe, Nasdaq and the press.
- **No consolidated US share volume for 10/30 from Cboe.** The Cboe market-share page exposes only 30-day and month-to-date aggregates, so the "19.87B shares vs a 17.26B 20-day average" figure in §1 is a **press number**, not a Cboe-verified one. The ETF relative-volume column is the substitute and it is directly measured.
- **No cap-weighted sector aggregate** — the EOD file's market-cap column is company-level and stamped on every share class (the 10-30 run blanked 11 sibling class rows for exactly this reason). §2 ranks sectors on official ETF closes and cross-checks with advance/decline breadth.
- **No Russell 2000 future**, from CNBC or any other symbol variant.
- **No consolidated after-hours tape** from Nasdaq (`/extended-trading` returned an empty table and a prior-session close in the 10-29 run). The after-hours board here is the TradingView `postmarket_*` columns, cross-checked against Cboe's own `current_price` — an agreement that held to the cent on every name checked.
- **No Nasdaq Composite or Nasdaq-100 row in the EOD file**, and the Nasdaq historical endpoint had not ingested the 10/30 row at the time of the run, so the 10-session index tables use Cboe's history CSVs.
- **No confirmed catalyst** for fourteen regular-session movers (MEOH, GDDY, OLN, INTA, HGV, RKT, MHK, CSGP, MIAX, SPOT, TMUS, ACN, CMCSA, PGEN) and for nine after-hours movers (ZJYL, BBNX, EVMN, AFYA, DCH, UNF, CLRO, PCLA, CDZI). These are marked unconfirmed rather than explained.
- **The PGEN after-hours level is unstable** across venues ($4.82 at 17:22, $5.15 at 03:14, $5.30 at 20:00) and the causal story is a market read-through, not company news. The −23.63% figure is the ~20:00 ET print.
- **No shibui 10/30 bar** — its EOD ingest lags past the close, so shibui's role this run was history and prior-close verification only, never today's close.

### Data lineage

```
Cash close (16:00 ET, 2026-10-30)
 ├─ Indices          Cboe _SPX/_NDX/_RUT/_DJX  +  Nasdaq /info COMP & NDX  +  Cboe history CSVs
 ├─ SOX              Nasdaq index page (cross-checked vs YCharts, Investing.com)
 ├─ ETFs & sectors   Cboe delayed_quotes  →  validated vs TradingView (19/19) and shibui prior close (19/19)
 ├─ Per-stock        TradingView america/scan  →  validated vs Cboe (26/26 identical closes)
 ├─ After-hours      TradingView postmarket_* (vs the 10/30 close)
 │                    ↳ cross-checked vs Cboe current_price (identical to the cent on every name)
 ├─ Futures          CNBC quote service (Friday 17:40 ET Globex settle)
 ├─ Yields           US Treasury daily yield-curve CSV (official)
 ├─ Volume ratios    TradingView relative_volume_10d_calc
 ├─ Breadth          TradingView universe (cap > $200M, vol > 100k, n=3,245) + cron #20 EOD file (n=4,898)
 ├─ Put/call         Cboe daily options statistics (embedded JSON payload)
 └─ Context/catalysts  AP, Reuters, Investopedia, CNBC, MarketChameleon, TipRanks, StockTitan,
                       Yahoo Finance, StockStory, Seeking Alpha, FT (via secondary), Binance/coindesk,
                       Cointelegraph, Mintrade, StockAnalysis, SEC EDGAR (8-K), BLS, via web_search/web_fetch
```

**Audit log:** skipped per the Cloud rule (no Windows audit file in this runtime).
